Regardless of the mechanism, changes in lipid metabolism may serve as useful markers for early diagnosis.
Promising markers for early myocardial ischemia have been described and should be developed further.
Currently the mass spectrometry based lipidomics has been successful in identifying lipid markers for early detection of disease.
Furthermore, our data suggest that serum hyaluronan level is a better marker than other serum markers for early evaluation of postoperative graft function.
Further comparisons of quantitative transmission parameters may help to identify relevant viral genetic markers for early detection of potentially more virulent strains during surveillance of LPAIV.
Accurate markers for early detection of tumors that should thus improve the efficacy of therapy are also awaited.
However, there are presently no tumor markers for early detection of the disease in otherwise healthy women [4].
Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, yet markers for early detection and intervention are currently lacking.
To pinpoint the cellular endosome compartment, which Tfn is trapped in, EEA1, RAB11 and ARF6 were used as markers for early and recycling endosomes.
These genes are more likely to be useful as prognostic tissue markers than as serum markers for early detection of aggressive disease.
EEA-1, transferrin receptor, LAMP-1, Golgin-97, and BIP proteins function as markers for early endosomes, recycling endosomes, late endosomes/lysosomes, Golgi and ER, respectively.
